Cagrilintide · 10 mg Vial
Cagrilintide is dosed at 600 mcg–4.5 mg weekly by subcutaneous injection in educational protocols, starting low and titrating upward.
- Typical weekly range
- 0.6–4.5 mg once weekly (gradual titration over 4–6 weeks).
| Week/Phase | Weekly Dose (mg) |
|---|---|
| Weeks 1–2 | 0.6 mg |
| Weeks 3–4 | 1.2 mg |
| Weeks 5–6 | 2.4 mg |
| Weeks 7–16 (Maintenance) | 4.5 mg |
3 ml conversion
5 mg + 3 ml = 1.67 mg/ml. Choose your vial strength to update the units below.
| Source dose | U-100 syringe |
|---|---|
| 0.6 mg | 36 units |
| 1.2 mg | 72 units |
| 2.4 mg | 144 units |
| 4.5 mg | 270 units |
